Axogen

AXGNNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$2.695 B

$45.93 +3.84%

Close of 21 Sept 2026

Revenue

$225.2M

#2253 by revenue

Earnings

-$15.7M

Loss-making

Shares outstanding

53,761,513

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#3IntegerITGR$4.30B
#4TransMedics GroupTMDX$3.03B
#5AxogenAXGN$2.69B
#6Biolife SolutionsBLFS$1.82B
#7CONMEDCNMD$1.34B

What if Axogen were worth as much as…

Open the what-if tool →

Gold $30.3T

$515,992.39

Per share 11,234× higher

Bitcoin $1.72T

$29,312.41

Per share 638× higher

Nvidia $5.48T

$93,398.95

Per share 2,034× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Axogen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.